What is Global Blood Screening and Typing Market?
The Global Blood Screening and Typing Market is a significant sector in the healthcare industry that focuses on the testing and identification of blood types and diseases. This market is crucial for ensuring the safety and compatibility of blood used in transfusions and other medical procedures. The process involves rigorous screening of donated blood for various infectious diseases like HIV, Hepatitis B and C, and syphilis, among others. Blood typing, on the other hand, is essential to determine the specific blood group of an individual, which is vital in cases of blood transfusions and organ transplants. The market's value was estimated at US$ 6668.3 million in 2023 and is projected to reach US$ 8357.6 million by 2030.
Nucleic Acid Amplification Technology, Immunohematology, Microbiological Technique, Other in the Global Blood Screening and Typing Market:
The Global Blood Screening and Typing Market employs several technologies, including Nucleic Acid Amplification Technology (NAAT), Immunohematology, and Microbiological Technique. NAAT is a high-performance testing method used to detect early infections by amplifying the nucleic acids present in the pathogens. Immunohematology, on the other hand, is the study of the reactions that occur between antigens present on blood cells and antibodies found in plasma. It plays a crucial role in ensuring safe blood transfusion and pregnancy. The Microbiological Technique is used to detect and identify bacteria and viruses in the blood. Other technologies used in this market include Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blotting, and Next-Generation Sequencing (NGS).
Reference Laboratories, Standalone Blood Banks, Hospitals in the Global Blood Screening and Typing Market:
The Global Blood Screening and Typing Market finds its applications in various areas such as Reference Laboratories, Standalone Blood Banks, and Hospitals. Reference Laboratories are independent labs that perform specific and specialized tests. They play a crucial role in disease diagnosis and monitoring. Standalone Blood Banks are institutions where blood and blood products are stored for later use. They are responsible for the collection, testing, processing, storage, and distribution of blood. Hospitals, on the other hand, are the primary consumers of screened and typed blood, using it for various procedures like surgeries, transfusions, and treatments.
Global Blood Screening and Typing Market Outlook:
In 2023, the Global Blood Screening and Typing Market was valued at US$ 6668.3 million. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 2.8% and reach a value of US$ 8357.6 million by 2030. This growth can be attributed to the increasing demand for blood and blood products, advancements in technology, and the rising prevalence of infectious diseases. On a broader scale, the global market for medical devices, which includes blood screening and typing, was estimated at US$ 603 billion in 2023. It is projected to grow at a CAGR of 5% over the next six years.
| Report Metric | Details |
| Report Name | Blood Screening and Typing Market |
| Accounted market size in 2023 | US$ 6668.3 million |
| Forecasted market size in 2030 | US$ 8357.6 million |
| CAGR | 2.8% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Abbott Laboratories, Agena Bioscience, Axo Science, Bag Health Care Gmbh, Becton, Dickinson, Bio-Rad Laboratories, Biomerieux, Danaher, Day Medical, Diagast, F. Hoffmann-La Roche, Grifols, Immucor, Novacyt Group, Ortho Clinical Diagnostics, Quotient, Siemens Healthcare, Thermo Fisher Scientific |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
